NCT03651336View on ClinicalTrials.gov

Long-term Safety and Performance of the ARGOS-IO Intraocular Pressure Sensor System in Subjects With Primary Open Angle Glaucoma (POAG)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 15, 2018

Primary Completion Date

April 27, 2022

Study Completion Date

April 27, 2022

Conditions

Primary Open-angle Glaucoma

Interventions

DEVICE

ARGOS-IO Sensor Pressure System

The ARGOS-IO Pressure sensor have been additionally implanted during local routine working procedures for cataract surgery in Patients with Primary Open Angle Glaucoma (POAG) and indicated cataract surgery in previous studies ARGOS-01 and ARGOS-02

Trial Locations (4)

39120

Universitätsaugenklinik Magdeburg, Magdeburg

44892

Universitäts-Augenklinik Bochum, Bochum

52074

Klinik für Augenheilkunde, Uniklinik RWTH Aachen, Aachen

72076

Universitäts-Augenklinik Tübingen, Tübingen

All Listed Sponsors

lead

Implandata Ophthalmic Products GmbH

INDUSTRY

NCT03651336 - Long-term Safety and Performance of the ARGOS-IO Intraocular Pressure Sensor System in Subjects With Primary Open Angle Glaucoma (POAG) | Biotech Hunter | Biotech Hunter